Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-26 @ 12:04 AM
Study NCT ID:
NCT06656494
Status:
RECRUITING
Last Update Posted:
2025-07-08
First Post:
2024-10-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-21
First Submit QC Date:
None
Study First Post Date:
2024-10-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-03
Last Update Post Date:
2025-07-08
Last Update Post Date Type:
ACTUAL